Radcliffe Capital Management »

Ys Biopharma shares owned by Radcliffe Capital Management

Quarter-by-quarter ownership of Ys Biopharma (YSBPW) shares owned by Radcliffe Capital Management from 13F filings

Historical chart of Radcliffe Capital Management investment in Ys Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ys Biopharma held by Radcliffe Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ys Biopharma by Radcliffe Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.4k 58k 0.04
2023-06-30 $5.4k 100k 0.05
2023-03-31 $16k 100k 0.16

More positions owned by Radcliffe Capital Management

Alteryx Conv (Principal)
Spotify Technology Conv (Principal)
Magnite Conv (Principal)
Alteryx Conv (Principal)
Compass Digital Acquisition Corp Common Stock (CDAQ)
DocuSign Conv (Principal)
Prospect Capital Corp Conv (Principal)
Ares Acquisition Corp Common Stock
Churchill Capital Corp VII Common Stock (CVII)
Ares Acquisition Corp II Common Stock (AACT)
Apollo Strategic Growth Capital II Common Stock
Globus Medical Conv (Principal)
Screaming Eagle Acquisition Corp Common Stock (SCRM)
Enphys Acquisition Corp Common Stock (NFYS)
CF Acquisition Corp IV Common Stock

View all positions for Radcliffe Capital Management

Top funds holding Ys Biopharma

Millennium Management
LMR Partners
Valliance Asset Management
BFAM Partners
Highbridge Capital Management
Jane Street
Cowen And Company
Bracebridge Capital
Calamos Advisors
Whitebox Advisors
D. E. Shaw & Co
Walleye Trading Advisors
Saba Capital Management
Cantor Fitzgerald, L. P.
Deutsche Bank Aktiengesellschaft

View all funds holding Ys Biopharma